SEPT. 30, 2014, ROCHESTER, Minn. — Mayo Clinic announced today that it is part of a team of research centers chosen by Patient-Centered Outcomes Research Institute (PCORI) and the Agency for Healthcare Research and Quality (AHRQ) to evaluate the effectiveness of different treatment strategies for women with uterine fibroids.
AHRQ has awarded the team a $3.95 million, first-year grant for the project, called Comparing Options for Management: Patient-Centered Results for Uterine Fibroids (COMPARE-UF). Duke Clinical Research Institute (DCRI) will serve as the research and data coordinating center for the teams.
“We are very excited to have funding to provide the key clinical evidence that all women and their physicians need to make informed choices about fibroid treatments,” says Elizabeth Stewart, M.D., chair of Reproductive Endocrinology at Mayo Clinic and the clinical leader of the study.
Tags: African American women, Agency for Healthcare Research and Quality, AHRQ, Elizabeth (Ebbie) A. Stewart M.D., health disparities, Mayo Clinic, News, news, Patient-Centered Outcomes Research Institute, PCORI, top news, uterine fibroids